AI-powered stethoscope can detect fatal heart diseases in 15 seconds: Study

An innovative stethoscope powered by artificial intelligence has emerged from Eko Health, a California-based company, bringing groundbreaking advancements in cardiac care. This device has been validated by researchers at Imperial College London and Imperial College Healthcare NHS Trust, demonstrating its ability to identify three critical heart conditions: heart failure, atrial fibrillation, and heart valve disease, all within a mere 15 seconds. The AI stethoscope uniquely combines traditional auscultation with advanced features, including a built-in microphone and electrocardiogram (ECG) technology. This allows it to detect subtle variations in heart rhythm and blood flow that are typically inaudible to the human ear. Collected data is securely transmitted to the cloud, where sophisticated algorithms analyze it using insights from tens of thousands of patient records. The results are then sent directly to healthcare providers' smartphones, enabling prompt action if a patient is identified as at risk. This cutting-edge technology was evaluated in the UK as part of the TRICORDER study, involving over 12,700 patients across 200 general practitioner (GP) practices serving a population of approximately 1.5 million. Patients exhibiting symptoms such as breathlessness, fatigue, or leg swelling were assessed with the AI stethoscope, and their diagnoses were compared to those of patients at practices without the device. The findings, which were presented at the European Society of Cardiology annual congress in Madrid, were striking. Patients who underwent evaluation with the AI stethoscope were found to be 2.3 times more likely to receive a heart failure diagnosis, 3.5 times more likely to be diagnosed with atrial fibrillation, and nearly double the likelihood of being identified with heart valve disease within a one-year period. The early detection capabilities of this technology could enable healthcare providers to initiate lifesaving treatments sooner, potentially avoiding situations where patients are only treated in emergency settings. However, the study also revealed some challenges. Approximately 70% of GP practices that received the devices ceased regular usage after one year. Researchers emphasized the need for better integration of the technology into clinical workflows and enhanced training for practitioners. Additionally, the device has been associated with false positives, as some patients were flagged as at risk, only to be cleared upon further testing. While this could lead to unnecessary investigations, experts argue that it is more beneficial than overlooking serious conditions that might otherwise go undiagnosed. With a footprint comparable to a playing card, the AI stethoscope is not designed for routine check-ups in healthy individuals, but it holds significant potential in primary care settings where timely diagnosis is vital. Researchers are optimistic that overcoming adoption challenges could herald a new era for the stethoscope, marking the most significant advancement in over 200 years.